Apellis Pharmaceuticals Stock Price History
APLS Stock | USD 26.33 0.57 2.12% |
If you're considering investing in Apellis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Apellis Pharmaceuticals stands at 26.33, as last reported on the 26th of February, with the highest price reaching 28.14 and the lowest price hitting 26.28 during the day. Apellis Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had a -0.1 % return per unit of standard deviation over the last 3 months. Apellis Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Apellis Pharmaceuticals' mean deviation of 2.11, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide.
Apellis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Apellis |
Sharpe Ratio = -0.1021
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | APLS |
Estimated Market Risk
3.22 actual daily | 28 72% of assets are more volatile |
Expected Return
-0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Apellis Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Apellis Pharmaceuticals by adding Apellis Pharmaceuticals to a well-diversified portfolio.
Apellis Pharmaceuticals Stock Price History Chart
There are several ways to analyze Apellis Stock price data. The simplest method is using a basic Apellis candlestick price chart, which shows Apellis Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 2, 2024 | 35.42 |
Lowest Price | February 26, 2025 | 26.33 |
Apellis Pharmaceuticals February 26, 2025 Stock Price Synopsis
Various analyses of Apellis Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Apellis Stock. It can be used to describe the percentage change in the price of Apellis Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Apellis Stock.Apellis Pharmaceuticals Price Action Indicator | (1.17) | |
Apellis Pharmaceuticals Accumulation Distribution | 115,797 | |
Apellis Pharmaceuticals Price Daily Balance Of Power | (0.31) | |
Apellis Pharmaceuticals Price Rate Of Daily Change | 0.98 |
Apellis Pharmaceuticals February 26, 2025 Stock Price Analysis
Apellis Stock Price History Data
Open | High | Low | Close | Volume | ||
02/26/2025 | 27.20 | 28.14 | 26.28 | 26.33 | 1,751,893 | |
02/25/2025 | 27.68 | 27.68 | 26.56 | 26.90 | 1,805,145 | |
02/24/2025 | 27.51 | 27.70 | 26.95 | 27.41 | 1,544,775 | |
02/21/2025 | 28.68 | 28.98 | 27.46 | 27.52 | 1,335,382 | |
02/20/2025 | 28.54 | 28.92 | 27.92 | 28.35 | 1,610,664 | |
02/19/2025 | 27.89 | 28.46 | 27.89 | 28.39 | 1,042,119 | |
02/18/2025 | 27.55 | 28.59 | 27.45 | 28.18 | 1,351,259 | |
02/14/2025 | 27.77 | 28.23 | 27.02 | 27.40 | 1,287,866 | |
02/13/2025 | 28.67 | 28.68 | 26.84 | 27.46 | 2,441,095 | |
02/12/2025 | 27.82 | 28.54 | 27.61 | 28.51 | 925,426 | |
02/11/2025 | 28.68 | 29.14 | 28.37 | 28.53 | 794,818 | |
02/10/2025 | 29.69 | 29.69 | 28.55 | 28.68 | 1,816,880 | |
02/07/2025 | 30.00 | 30.26 | 29.03 | 29.39 | 880,483 | |
02/06/2025 | 30.39 | 30.53 | 29.53 | 30.20 | 1,413,367 | |
02/05/2025 | 29.17 | 30.60 | 29.08 | 30.37 | 1,988,990 | |
02/04/2025 | 28.59 | 29.13 | 28.23 | 28.78 | 1,521,256 | |
02/03/2025 | 28.36 | 28.83 | 27.91 | 28.49 | 1,502,024 | |
01/31/2025 | 30.30 | 30.60 | 28.97 | 29.01 | 1,459,378 | |
01/30/2025 | 29.70 | 30.50 | 29.41 | 30.39 | 1,070,153 | |
01/29/2025 | 29.29 | 29.81 | 29.11 | 29.47 | 1,178,488 | |
01/28/2025 | 29.97 | 30.11 | 28.72 | 29.28 | 2,589,526 | |
01/27/2025 | 30.13 | 30.80 | 29.36 | 29.79 | 1,669,572 | |
01/24/2025 | 30.74 | 30.91 | 29.67 | 30.00 | 1,530,766 | |
01/23/2025 | 30.24 | 31.17 | 30.23 | 30.76 | 1,345,264 | |
01/22/2025 | 30.02 | 30.84 | 29.96 | 30.39 | 1,315,469 | |
01/21/2025 | 30.26 | 30.52 | 29.39 | 30.13 | 1,461,293 | |
01/17/2025 | 30.03 | 30.35 | 29.61 | 29.94 | 1,510,922 | |
01/16/2025 | 29.15 | 30.12 | 29.15 | 29.73 | 1,344,132 | |
01/15/2025 | 28.33 | 30.13 | 28.25 | 29.03 | 2,088,859 | |
01/14/2025 | 29.25 | 29.25 | 27.61 | 27.69 | 1,695,248 | |
01/13/2025 | 28.58 | 29.67 | 27.63 | 28.59 | 3,671,261 | |
01/10/2025 | 30.00 | 30.38 | 27.35 | 27.44 | 3,958,693 | |
01/08/2025 | 34.30 | 34.48 | 32.96 | 33.00 | 1,621,071 | |
01/07/2025 | 34.53 | 35.57 | 33.83 | 34.63 | 1,852,633 | |
01/06/2025 | 33.68 | 35.14 | 33.36 | 34.38 | 4,122,859 | |
01/03/2025 | 33.24 | 34.15 | 33.16 | 33.46 | 2,742,562 | |
01/02/2025 | 32.32 | 33.50 | 31.87 | 33.16 | 1,219,736 | |
12/31/2024 | 32.10 | 32.74 | 31.43 | 31.91 | 977,704 | |
12/30/2024 | 32.13 | 32.50 | 31.88 | 31.90 | 3,050,175 | |
12/27/2024 | 32.86 | 33.33 | 32.44 | 32.68 | 942,145 | |
12/26/2024 | 33.05 | 33.23 | 32.33 | 32.96 | 1,062,450 | |
12/24/2024 | 33.21 | 33.39 | 32.50 | 33.32 | 437,759 | |
12/23/2024 | 33.35 | 33.83 | 32.79 | 33.21 | 1,256,144 | |
12/20/2024 | 33.16 | 34.27 | 32.89 | 33.21 | 3,733,222 | |
12/19/2024 | 34.13 | 34.25 | 32.88 | 33.14 | 3,052,761 | |
12/18/2024 | 34.53 | 35.71 | 33.73 | 34.02 | 1,691,945 | |
12/17/2024 | 32.98 | 34.83 | 32.74 | 34.53 | 2,328,655 | |
12/16/2024 | 33.19 | 34.98 | 32.71 | 33.66 | 5,345,242 | |
12/13/2024 | 32.60 | 33.50 | 31.76 | 33.19 | 5,506,929 | |
12/12/2024 | 33.53 | 34.10 | 32.30 | 32.74 | 2,991,194 | |
12/11/2024 | 34.92 | 34.97 | 33.97 | 34.00 | 1,359,624 | |
12/10/2024 | 35.22 | 35.35 | 34.21 | 34.64 | 1,193,881 | |
12/09/2024 | 33.80 | 35.72 | 33.35 | 35.02 | 5,323,498 | |
12/06/2024 | 33.74 | 34.37 | 33.16 | 33.49 | 2,350,326 | |
12/05/2024 | 33.97 | 34.23 | 32.67 | 33.45 | 5,180,081 | |
12/04/2024 | 34.62 | 34.76 | 33.76 | 34.13 | 1,139,075 | |
12/03/2024 | 35.01 | 35.38 | 33.82 | 34.63 | 3,674,912 | |
12/02/2024 | 33.95 | 35.53 | 33.60 | 35.42 | 2,148,378 | |
11/29/2024 | 34.14 | 34.69 | 33.78 | 33.93 | 1,134,980 | |
11/27/2024 | 33.09 | 34.40 | 32.77 | 34.14 | 2,044,518 | |
11/26/2024 | 32.29 | 32.98 | 31.80 | 32.63 | 3,302,078 |
About Apellis Pharmaceuticals Stock history
Apellis Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Apellis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Apellis Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Apellis Pharmaceuticals stock prices may prove useful in developing a viable investing in Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Apellis Pharmaceuticals, Inc. was incorporated in 2009 and is based in Waltham, Massachusetts. Apellis Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 476 people.
Apellis Pharmaceuticals Stock Technical Analysis
Apellis Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
All Next | Launch Module |
Apellis Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Apellis Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Apellis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Apellis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.07) | |||
Jensen Alpha | (0.33) | |||
Total Risk Alpha | (0.31) | |||
Treynor Ratio | (0.32) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Apellis Stock Analysis
When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.